IFG Advisory’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.11K | Sell |
75
-33,178
| -100% | -$883K | 0.01% | 309 |
|
|
2025
Q4 | $828K | Sell |
33,253
-2,831
| -8% | -$71.4K | 0.04% | 411 |
|
|
2025
Q3 | $919K | Sell |
36,084
-1,962
| -5% | -$48.4K | 0.04% | 373 |
|
|
2025
Q2 | $922K | Sell |
38,046
-1,135
| -3% | -$26.5K | 0.05% | 362 |
|
|
2025
Q1 | $993K | Buy |
39,181
+36
| +0.1% | +$942 | 0.06% | 321 |
|
|
2024
Q4 | $1.04M | Sell |
39,145
-1,804
| -4% | -$48.9K | 0.06% | 288 |
|
|
2024
Q3 | $1.19M | Buy |
40,949
+2,764
| +7% | +$80.6K | 0.08% | 257 |
|
|
2024
Q2 | $1.07M | Buy |
38,185
+2,478
| +7% | +$68.2K | 0.07% | 269 |
|
|
2024
Q1 | $991K | Sell |
35,707
-5,481
| -13% | -$152K | 0.07% | 249 |
|
|
2023
Q4 | $1.19M | Sell |
41,188
-43,338
| -51% | -$1.31M | 0.09% | 232 |
|
|
2023
Q3 | $2.8M | Buy |
84,526
+225
| +0.3% | +$7.96K | 0.24% | 115 |
|
|
2023
Q2 | $3.09M | Buy |
84,301
+17,370
| +26% | +$676K | 0.27% | 103 |
|
|
2023
Q1 | $2.73M | Buy |
66,931
+4,273
| +7% | +$185K | 0.26% | 89 |
|
|
2022
Q4 | $3.21M | Sell |
62,658
-10,920
| -15% | -$524K | 0.32% | 72 |
|
|
2022
Q3 | $3.22M | Buy |
73,578
+15,691
| +27% | +$762K | 0.29% | 74 |
|
|
2022
Q2 | $3.03M | Buy |
57,887
+10,385
| +22% | +$529K | 0.32% | 64 |
|
|
2022
Q1 | $2.46M | Buy |
47,502
+4,779
| +11% | +$248K | 0.25% | 99 |
|
|
2021
Q4 | $2.52M | Sell |
42,723
-8,847
| -17% | -$438K | 0.25% | 94 |
|
|
2021
Q3 | $2.22M | Buy |
51,570
+5,055
| +11% | +$224K | 0.24% | 106 |
|
|
2021
Q2 | $1.82M | Buy |
46,515
+10,242
| +28% | +$398K | 0.2% | 127 |
|
|
2021
Q1 | $1.31M | Sell |
36,273
-4,969
| -12% | -$176K | 0.16% | 149 |
|
|
2020
Q4 | $1.52M | Sell |
41,242
-1,736
| -4% | -$63.7K | 0.21% | 121 |
|
|
2020
Q3 | $1.5M | Buy |
42,978
+853
| +2% | +$29.9K | 0.24% | 99 |
|
|
2020
Q2 | $1.31M | Buy |
42,125
+88
| +0.2% | +$2.99K | 0.24% | 100 |
|
|
2020
Q1 | $1.3M | Buy |
42,037
+4,653
| +12% | +$159K | 0.29% | 86 |
|
|
2019
Q4 | $1.39M | Sell |
37,384
-5,112
| -12% | -$182K | 0.25% | 102 |
|
|
2019
Q3 | $1.45M | Sell |
42,496
-492
| -1% | -$17.9K | 0.28% | 97 |
|
|
2019
Q2 | $1.77M | Buy |
42,988
+4,763
| +12% | +$189K | 0.31% | 70 |
|
|
2019
Q1 | $1.54M | Buy |
38,225
+472
| +1% | +$18.9K | 0.29% | 71 |
|
|
2018
Q4 | $1.56M | Sell |
37,753
-2,818
| -7% | -$117K | 0.37% | 64 |
|
|
2018
Q3 | $1.7M | Sell |
40,571
-618
| -2% | -$23.8K | 0.32% | 72 |
|
|
2018
Q2 | $1.42M | Buy |
41,189
+1,315
| +3% | +$44.9K | 0.29% | 80 |
|
|
2018
Q1 | $1.34M | Sell |
39,874
-1,615
| -4% | -$55.5K | 0.3% | 79 |
|
|
2017
Q4 | $1.43M | Buy |
+41,489
| New | +$1.41M | 0.32% | 76 |
|
Other funds holding PFE
VCM
VPM
IFG Advisory's PFE Position: Q1 2026 in Review
IFG Advisory reduced its Pfizer (PFE) stake by 100% in Q1 2026, selling an estimated $883K and leaving 75 shares worth $2.11K. The position accounts for 0.01% of the portfolio, ranked #309.
IFG Advisory first reported a position in PFE in Q4 2017 and has held it in 34 quarters since. The position peaked at $3.22M in Q3 2022. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- IFG Advisory held 75 shares of Pfizer worth $2.11K as of Q1 2026.
- IFG Advisory sold 33,178 Pfizer shares in Q1 2026, an estimated $883K.
- Pfizer made up 0.01% of IFG Advisory's portfolio in Q1 2026, its #309 holding.
- IFG Advisory first reported a position in Pfizer in Q4 2017 and has held it in 34 quarters since.
- IFG Advisory's Pfizer position peaked at $3.22M in Q3 2022.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on IFG Advisory's 13F filing for Q1 2026, filed 12 May 2026.